News
October 29, 2020

Regenstrief and Ventech Solutions partner to develop and validate innovative healthcare solutions

Regenstrief Institute and Ventech Solutions, Inc. are working together to develop, validate and deploy high-performance health data innovations to improve health and healthcare. The partnership will create and curate data solutions and datasets to enrich population health and outcomes research.

Regenstrief Institute, based in Indianapolis, is an internationally recognized expert in health data analytics. Ventech Solutions, headquartered in Columbus, Ohio, works with the U.S. Centers for Medicare and Medicaid Services and manages and operates the systems that drive our national healthcare providing Health Care Quality Information Systems infrastructure and data support. Their platforms provide high levels of security, compliance and regulation for healthcare data.

Academic and healthcare institutions will be able to add their data to a data lake through Ventech Solutions’ QurData platform, and researchers will be able to request customized datasets to answer research questions. Regenstrief scientists will provide guidance to analyze and curate the data.

“Our industry-leading technology combined with Regenstrief’s experience in informatics and artificial intelligence will open new doors for researchers in search of answers through healthcare data,” said Ravi Kunduru, president and chief executive officer of Ventech Solutions. “We hope this collaboration will lead to many solutions.”

“We are very excited about this partnership with Regenstrief Institute,” said DJ Nag, PhD, chief partnership officer of Ventech Solutions. “We look forward to their guidance as we move forward in putting health data to work.”

About Regenstrief Institute

Founded in 1969 in Indianapolis, the Regenstrief Institute is a local, national and global leader dedicated to a world where better information empowers people to end disease and realize true health. A key research partner to Indiana University, Regenstrief and its research scientists are responsible for a growing number of major healthcare innovations and studies. Examples range from the development of global health information technology standards that enable the use and interoperability of electronic health records to improving patient-physician communications, to creating models of care that inform practice and improve the lives of patients around the globe.

Sam Regenstrief, a nationally successful entrepreneur from Connersville, Indiana, founded the institute with the goal of making healthcare more efficient and accessible for everyone. His vision continues to guide the institute’s research mission.

About Ventech Solutions

Ventech Solutions (www.ventechsolutions.com), an advanced AWS consulting partner, is an enterprise cloud modernization and service integrator provider for the U.S. public sector.  Ventech Solutions works with the U.S. Centers for Medicare and Medicaid Services and manages and operates the systems that drive national healthcare providing health care quality information systems infrastructure and data support. QurData is Ventech Solution’s secured, governed, and compliant AWS cloud infrastructure data platform, which enables real-world data and real-world evidence (RWD/RWE) research and analytics on large healthcare datasets.

  • Ventech Logo

Related News

Dr. Babar Khan on All IN

Mobile Critical Care Recovery Program for Survivors of Acute Respiratory Failure: A Randomized Clinical Trial

Published in JAMA Network Open. Here is a link to the article. Regenstrief Institute authors: Babar Khan, M.D., M.S.,

Expanding health equity by including nursing home residents in clinical trials

INDIANAPOLIS – Clinical trials are constantly being designed and study participants enrolled to determine if medical treatments and therapies

photo background showing data, etc.

Regenstrief Institute will host collaborative conference to improve public health data

Due to previous year’s high demand, virtual attendance option added  The Public Health Informatics Program in the Center for

Study reports chlamydia and gonorrhea more likely to be treated per CDC guidelines in males, younger patients and individuals identifying as Black or multiracial

Study reports chlamydia and gonorrhea more likely to be treated per CDC guidelines in males, younger patients and individuals identifying as Black or multiracial

But significant numbers of those living with these diseases don’t receive this treatment INDIANAPOLIS – Chlamydia and gonorrhea are